New kidney stone drug shows promise in early trial
NCT ID NCT06932146
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tested an experimental drug called LLX-424 in 51 adults who have had kidney stones before. The drug aims to lower oxalate levels in urine, which can help prevent new stones from forming. Participants took either the drug or a placebo for 8 weeks, and researchers checked for side effects and changes in urine oxalate. The trial is complete, and results will help decide if larger studies are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY STONES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Site #1
San Antonio, Texas, 78217, United States
-
Clinical Research Site #2
Saint Paul, Minnesota, 55114, United States
-
Clinical Research Site #3
Springfield, Missouri, 65802, United States
Conditions
Explore the condition pages connected to this study.